K. Peignaux-Casasnovas

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial

Philip Poortmans, Caroline Weltens, Catherine Fortpied et al. · The Lancet Oncology · 2020 · 288 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer

G. Créhange, Céline Mirjolet, Mélanie Gauthier et al. · Radiotherapy and Oncology · 2011 · 50 citations

Medicine, Oncology, Radiation Oncology +16

Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925

Philip Poortmans, H. Struikmans, Peter De Brouwer et al. · JNCI Journal of the National Cancer Institute · 2021 · 48 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease

M. Bolla, Anouk Neven, P. Maingon et al. · Journal of Clinical Oncology · 2021 · 48 citations · Full text

Medicine, Oncology, Radiation Oncology +17

The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial

Orit Kaidar‐Person, Catherine Fortpied, S. Hol et al. · Radiotherapy and Oncology · 2022 · 31 citations · Full text

Medicine, Oncology, Surgery +16